206 related articles for article (PubMed ID: 19176640)
1. BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer.
Rodriguez-Nieto S; Sanchez-Cespedes M
Carcinogenesis; 2009 Apr; 30(4):547-54. PubMed ID: 19176640
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.
Sanchez-Cespedes M; Parrella P; Esteller M; Nomoto S; Trink B; Engles JM; Westra WH; Herman JG; Sidransky D
Cancer Res; 2002 Jul; 62(13):3659-62. PubMed ID: 12097271
[TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
[TBL] [Abstract][Full Text] [Related]
4. Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines.
Medina PP; Romero OA; Kohno T; Montuenga LM; Pio R; Yokota J; Sanchez-Cespedes M
Hum Mutat; 2008 May; 29(5):617-22. PubMed ID: 18386774
[TBL] [Abstract][Full Text] [Related]
5. Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene.
Carretero J; Medina PP; Pio R; Montuenga LM; Sanchez-Cespedes M
Oncogene; 2004 May; 23(22):4037-40. PubMed ID: 15021901
[TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic alterations of BRG1 promote oral cancer development.
Gunduz E; Gunduz M; Ouchida M; Nagatsuka H; Beder L; Tsujigiwa H; Fukushima K; Nishizaki K; Shimizu K; Nagai N
Int J Oncol; 2005 Jan; 26(1):201-10. PubMed ID: 15586241
[TBL] [Abstract][Full Text] [Related]
7. LKB1 mutation in large cell carcinoma of the lung.
Zhong D; Guo L; de Aguirre I; Liu X; Lamb N; Sun SY; Gal AA; Vertino PM; Zhou W
Lung Cancer; 2006 Sep; 53(3):285-94. PubMed ID: 16822578
[TBL] [Abstract][Full Text] [Related]
8. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines.
Wong AK; Shanahan F; Chen Y; Lian L; Ha P; Hendricks K; Ghaffari S; Iliev D; Penn B; Woodland AM; Smith R; Salada G; Carillo A; Laity K; Gupte J; Swedlund B; Tavtigian SV; Teng DH; Lees E
Cancer Res; 2000 Nov; 60(21):6171-7. PubMed ID: 11085541
[TBL] [Abstract][Full Text] [Related]
9. Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations.
Fernandez P; Carretero J; Medina PP; Jimenez AI; Rodriguez-Perales S; Paz MF; Cigudosa JC; Esteller M; Lombardia L; Morente M; Sanchez-Verde L; Sotelo T; Sanchez-Cespedes M
Oncogene; 2004 Jun; 23(29):5084-91. PubMed ID: 15077168
[TBL] [Abstract][Full Text] [Related]
10. Targeted knockout of BRG1 potentiates lung cancer development.
Glaros S; Cirrincione GM; Palanca A; Metzger D; Reisman D
Cancer Res; 2008 May; 68(10):3689-96. PubMed ID: 18483251
[TBL] [Abstract][Full Text] [Related]
11. Specific pattern of LKB1 and phospho-acetyl-CoA carboxylase protein immunostaining in human normal tissues and lung carcinomas.
Conde E; Suarez-Gauthier A; García-García E; Lopez-Rios F; Lopez-Encuentra A; García-Lujan R; Morente M; Sanchez-Verde L; Sanchez-Cespedes M
Hum Pathol; 2007 Sep; 38(9):1351-60. PubMed ID: 17521700
[TBL] [Abstract][Full Text] [Related]
12. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.
Glaros S; Cirrincione GM; Muchardt C; Kleer CG; Michael CW; Reisman D
Oncogene; 2007 Oct; 26(49):7058-66. PubMed ID: 17546055
[TBL] [Abstract][Full Text] [Related]
13. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis.
Reisman DN; Sciarrotta J; Wang W; Funkhouser WK; Weissman BE
Cancer Res; 2003 Feb; 63(3):560-6. PubMed ID: 12566296
[TBL] [Abstract][Full Text] [Related]
14. Expression of LKB1 tumor suppressor in non-small cell lung cancer determines sensitivity to 2-deoxyglucose.
Inge LJ; Coon KD; Smith MA; Bremner RM
J Thorac Cardiovasc Surg; 2009 Mar; 137(3):580-6. PubMed ID: 19258070
[TBL] [Abstract][Full Text] [Related]
15. SWI/SNF complex is essential for NRSF-mediated suppression of neuronal genes in human nonsmall cell lung carcinoma cell lines.
Watanabe H; Mizutani T; Haraguchi T; Yamamichi N; Minoguchi S; Yamamichi-Nishina M; Mori N; Kameda T; Sugiyama T; Iba H
Oncogene; 2006 Jan; 25(3):470-9. PubMed ID: 16247481
[TBL] [Abstract][Full Text] [Related]
16. Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer.
Gill RK; Yang SH; Meerzaman D; Mechanic LE; Bowman ED; Jeon HS; Roy Chowdhuri S; Shakoori A; Dracheva T; Hong KM; Fukuoka J; Zhang JH; Harris CC; Jen J
Oncogene; 2011 Sep; 30(35):3784-91. PubMed ID: 21532627
[TBL] [Abstract][Full Text] [Related]
17. LKB1 gene mutations in Japanese lung cancer patients.
Onozato R; Kosaka T; Achiwa H; Kuwano H; Takahashi T; Yatabe Y; Mitsudomi T
Cancer Sci; 2007 Nov; 98(11):1747-51. PubMed ID: 17711506
[TBL] [Abstract][Full Text] [Related]
18. The role of LKB1 in lung cancer.
Sanchez-Cespedes M
Fam Cancer; 2011 Sep; 10(3):447-53. PubMed ID: 21516316
[TBL] [Abstract][Full Text] [Related]
19. LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes.
Mehenni H; Lin-Marq N; Buchet-Poyau K; Reymond A; Collart MA; Picard D; Antonarakis SE
Hum Mol Genet; 2005 Aug; 14(15):2209-19. PubMed ID: 15987703
[TBL] [Abstract][Full Text] [Related]
20. The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer.
Sekine I; Sato M; Sunaga N; Toyooka S; Peyton M; Parsons R; Wang W; Gazdar AF; Minna JD
Oncogene; 2005 Apr; 24(16):2735-8. PubMed ID: 15735765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
